Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class Ila Histone Deacetylase (HDAC) Inhibitors

被引:41
作者
Luckhurst, Christopher A. [1 ]
Breccia, Perla [1 ]
Stott, Andrew J. [1 ]
Aziz, Omar [1 ]
Birch, Helen L. [1 ]
Buerli, Roland W. [1 ]
Hughes, Samantha J. [1 ]
Jarvis, Rebecca E. [1 ]
Lamers, Marieke [1 ]
Leonard, Philip M. [1 ]
Matthews, Kim L. [1 ]
McAllister, George [1 ]
Pollack, Scott [1 ]
Saville-Stones, Elizabeth [1 ]
Wishart, Grant [1 ]
Yates, Dawn [1 ]
Dominguez, Celia [2 ]
机构
[1] BioFocus, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England
[2] CHDI Management CHDI Fdn Inc, 6080 Ctr Dr,Suite 100, Los Angeles, CA 90045 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2016年 / 7卷 / 01期
关键词
Class IIa HDAC inhibitors; hydroxamic acid; CNS exposure; tetrasubstituted cyclopropane; cyclopropanation; Huntington's disease;
D O I
10.1021/acsmedchemlett.5b00302
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Potent and selective class Ha HDAC tetrasubstituted cyclopropane hydroxamic acid inhibitors were identified with high oral bioavailability that exhibited good brain and muscle exposure. Compound 14 displayed suitable properties for assessment of the impact of class Ha HDAC catalytic site inhibition in preclinical disease models.
引用
收藏
页码:34 / 39
页数:6
相关论文
共 15 条
  • [1] Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
    Beconi, Maria
    Aziz, Omar
    Matthews, Kim
    Moumne, Lara
    O'Connell, Catherine
    Yates, Dawn
    Clifton, Steven
    Pett, Hannah
    Vann, Julie
    Crowley, Lynsey
    Haughan, Alan F.
    Smith, Donna L.
    Woodman, Ben
    Bates, Gillian P.
    Brookfield, Fred
    Buerli, Roland W.
    McAllister, George
    Dominguez, Celia
    Munoz-Sanjuan, Ignacio
    Beaumont, Vahri
    [J]. PLOS ONE, 2012, 7 (09):
  • [2] Class II histone deacetylases: Structure, function, and regulation
    Bertos, NR
    Wang, AH
    Yang, XJ
    [J]. BIOCHEMISTRY AND CELL BIOLOGY, 2001, 79 (03) : 243 - 252
  • [3] Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain
    Bottomley, Matthew J.
    Lo Surdo, Paola
    Di Giovine, Paolo
    Cirillo, Agostino
    Scarpelli, Rita
    Ferrigno, Federica
    Jones, Philip
    Neddermann, Petra
    De Francesco, Raffaele
    Steinkuhler, Christian
    Gallinari, Paola
    Carfi, Andrea
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (39) : 26694 - 26704
  • [4] Bradner J. E., 2011, [No title captured], Patent No. [WO 2011084991, 2011084991, W02011084991]
  • [5] Chemical phylogenetics of histone deacetylases
    Bradner, James E.
    West, Nathan
    Grachan, Melissa L.
    Greenberg, Edward F.
    Haggarty, Stephen J.
    Warnow, Tandy
    Mazitschek, Ralph
    [J]. NATURE CHEMICAL BIOLOGY, 2010, 6 (03) : 238 - 243
  • [6] Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington's Disease
    Buerli, Roland W.
    Luckhurst, Christopher A.
    Aziz, Omar
    Matthews, Kim L.
    Yates, Dawn
    Lyons, Kathy. A.
    Beconi, Maria
    McAllister, George
    Breccia, Perla
    Stott, Andrew J.
    Penrose, Stephen D.
    Wall, Michael
    Lamers, Marieke
    Leonard, Philip
    Mueller, Ilka
    Richardson, Christine M.
    Jarvis, Rebecca
    Stones, Liz
    Hughes, Samantha
    Wishart, Grant
    Haughan, Alan F.
    O'Connell, Catherine
    Mead, Tania
    McNeil, Hannah
    Vann, Julie
    Mangette, John
    Maillard, Michel
    Beaumont, Vahri
    Munoz-Sanjuan, Ignacio
    Dominguez, Celia
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 9934 - 9954
  • [7] Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs
    Doan, KMM
    Humphreys, JE
    Webster, LO
    Wring, SA
    Shampine, LJ
    Serabjit-Singh, CJ
    Adkison, KK
    Polli, JW
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) : 1029 - 1037
  • [8] CYCLOPROPYL CARBANIONS DERIVED FROM ESTERS OF 2-PHENYLCYCLOPROPYLCARBOXYLIC ACIDS - CONFIGURATIONAL STABILITY AND REACTION WITH ELECTROPHILES
    FEIT, BA
    ELSER, R
    MELAMED, U
    GOLDBERG, I
    [J]. TETRAHEDRON, 1984, 40 (24) : 5177 - 5180
  • [9] Unraveling the hidden catalytic activity of vertebrate class Ila histone deacetylases
    Lahm, A.
    Paolini, C.
    Pallaoro, M.
    Nardi, M. C.
    Jones, P.
    Neddermann, P.
    Sambucini, S.
    Bottomley, M. J.
    Lo Surdo, P.
    Carfi, A.
    Koch, U.
    De Francesco, R.
    Steinkuehler, C.
    Gallinari, P.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (44) : 17335 - 17340
  • [10] Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
    Lauffer, Benjamin E. L.
    Mintzer, Robert
    Fong, Rina
    Mukund, Susmith
    Tam, Christine
    Zilberleyb, Inna
    Flicke, Birgit
    Ritscher, Allegra
    Fedorowicz, Grazyna
    Vallero, Roxanne
    Ortwine, Daniel F.
    Gunzner, Janet
    Modrusan, Zora
    Neumann, Lars
    Koth, Christopher M.
    Lupardus, Patrick J.
    Kaminker, Joshua S.
    Heise, Christopher E.
    Steiner, Pascal
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (37) : 26926 - 26943